Position in REPL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,566,650
-$466,986 QoQ
Shares Held
204,791
-2.1% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. REPL ranks #148 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in REPL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,566,650 | 204,791 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,033,636 | 209,222 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $843,474 | 201,307 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,918,959 | 206,562 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,844,473 | 189,177 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,113,411 | 174,518 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,782,368 | 162,625 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,622,034 | 180,226 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,329,707 | 162,755 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,421,069 | 168,573 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $2,864,743 | 167,431 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,906,438 | 168,236 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,061,729 | 173,371 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $4,557,876 | 167,569 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $2,531,125 | 146,562 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,833,546 | 104,894 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,852,110 | 109,076 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,966,961 | 109,482 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,731,888 | 92,169 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $3,009,592 | 78,334 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,654,918 | 87,018 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $1,458,362 | 63,352 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,229,775 | 49,488 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $338,231 | 33,925 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||